Ingevity Corporation (NYSE:NGVT) Given Average Rating of “Hold” by Brokerages

Ingevity Corporation (NYSE:NGVT) has been given an average recommendation of “Hold” by the five brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $67.50.

Several research firms have recently commented on NGVT. BMO Capital Markets upped their price objective on shares of Ingevity from $64.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Ingevity in a report on Thursday. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Thursday, January 22nd. Finally, Zacks Research raised Ingevity to a “hold” rating in a report on Tuesday, December 16th.

Ingevity Stock Performance

Ingevity stock traded up $0.73 during trading hours on Thursday, hitting $70.33. 729,970 shares of the stock traded hands, compared to its average volume of 313,473. The firm’s 50 day moving average price is $66.75 and its 200-day moving average price is $58.91. The company has a debt-to-equity ratio of 8.39, a current ratio of 1.27 and a quick ratio of 0.80. The stock has a market capitalization of $2.53 billion, a price-to-earnings ratio of -38.64 and a beta of 1.34. Ingevity has a 1 year low of $28.49 and a 1 year high of $77.46.

Ingevity (NYSE:NGVT) last released its earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). Ingevity had a positive return on equity of 103.69% and a negative net margin of 5.14%.The firm had revenue of $255.10 million for the quarter, compared to analyst estimates of $257.27 million. During the same period last year, the firm earned $0.95 EPS. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. As a group, equities analysts expect that Ingevity will post 4.45 EPS for the current fiscal year.

Institutional Trading of Ingevity

Hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its holdings in Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock valued at $518,000 after buying an additional 1,323 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Ingevity by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after purchasing an additional 1,080 shares in the last quarter. Empowered Funds LLC increased its stake in shares of Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after purchasing an additional 594 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares during the period. Finally, Jane Street Group LLC boosted its position in Ingevity by 306.1% during the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after purchasing an additional 66,995 shares in the last quarter. 91.59% of the stock is owned by hedge funds and other institutional investors.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.